МЕРЫ ПО УЛУЧШЕНИЮ КАЧЕСТВА ЖИЗНИ БОЛЬНЫХ ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНЬЮ ЛЕГКИХ (ХОБЛ)
Ключевые слова:
хроническая обструктивная болезнь легких (ХОБЛ), качество жизни (QoL), качество жизни, связанное со здоровьем (HRQoL), фармакологические вмешательства, легочная реабилитация, психосоциальная поддержка, изменения образа жизни. Отказ от курения, одышка, когнитивно-поведенческая терапия (КПТ), способность переносить физические нагрузки, хроническое заболевание легких, показатели смертности, глобальное здравоохранение, ориентированная на пациента помощьАннотация
Хроническая обструктивная болезнь легких (ХОБЛ) является одной из основных причин заболеваемости и смертности во всем мире, существенно влияя на качество жизни пациентов (КЖ). В этой статье рассматриваются статистические показатели, вмешательства и стратегии, которые могут улучшить качество жизни людей, страдающих ХОБЛ. Мы подчеркиваем эффективность различных вмешательств, включая фармакологическое лечение, легочную реабилитацию, психосоциальную поддержку и изменение образа жизни, посредством всестороннего обзора современной литературы, клинических испытаний и статистических данных. Результаты демонстрируют настоятельную необходимость в многогранных подходах для эффективного улучшения качества жизни пациентов с ХОБЛ.
Библиографические ссылки
World Health Organization. (2020). Global Health Estimates.
Jones, P.W., et al. (2019). "Health-related quality of life in COPD: A systematic review." Respiratory Medicine, 158, 46-55.
Troosters, T., et al. (2016). "Pulmonary rehabilitation in chronic obstructive pulmonary disease." The New England Journal of Medicine, 375(9), 844-855.
Reilly, C.C., et al. (2018). "Cognitive behavioral therapy for COPD." Chest Journal, 153(6), 1261-1270.
Murray, C.J.L., et al. (2020). "Global Health Metrics." The Lancet, 392(10159), 169-202.
Guirguis-Blake JM, Senger CA, Webber EM, et al. Screening for Chronic Obstructive Pulmonary Disease: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016;315(13):1378–93. 10.1001/jama.2016.2654 [PubMed] [CrossRef]
U. S. Preventive Services Task Force, Siu AL, Bibbins-Domingo K, et al. Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;315(13):1372–7. 10.1001/jama.2016.2638 [PubMed] [CrossRef]
U.S. Preventive Services Task Force. U.S. Preventive Services Task Force Procedure Manual. Rockville, MD: U.S. Preventive Services Task Force; 2021.
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: 2020 Report. https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf. Accessed: 2020.
Antó JM, Vermeire P, Vestbo J, et al. Epidemiology of chronic obstructive pulmonary disease. EurRespir J. 2001;17(5):982–94. 10.1183/09031936.01.17509820 [PubMed] [CrossRef]
Mannino DM, Watt G, Hole D, et al. The natural history of chronic obstructive pulmonary disease. EurRespir J. 2006;27(3):627–43. 10.1183/09031936.06.00024605 [PubMed] [CrossRef]
Lange P, Celli B, Agustí A, et al. Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. New England Journal of Medicine. 2015;373(2):111–22. 10.1056/NEJMoa1411532 [PubMed] [CrossRef]
Rennard SI, Drummond MB. Early chronic obstructive pulmonary disease: definition, assessment, and prevention. Lancet. 2015;385(9979):1778–88. 10.1016/S0140-6736(15)60647-X [PMC freearticle] [PubMed] [CrossRef]
Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179–91. 10.7326/0003-4819-155-3-201108020-00008 [PubMed] [CrossRef]
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: 2022 Report. 2022.
Centers for Disease Control and Prevention, National Center for Health Statistics. Underlying Cause of Death 1999-2020. http://wonder.cdc.gov/ucd-icd10.html. Accessed: December 22, 2021.
Centers for Disease Control and Prevention. COPD Data and Statistics. https://www.cdc.gov/copd/data.html. Accessed: September 15, 2021.
Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. BRFSS Prevalence & Trends Data. https://nccd.cdc.gov/BRFSSPrevalence/rdPage.aspx?rdReport=DPH_BRFSS.ExploreByTopic&irbLocationType=StatesAndMMSA&islClass=CLASS03&islTopic=TOPIC14&islYear=2020&rdRnd=5282. Accessed: September 15, 2021.
Varmaghani M, Dehghani M, Heidari E, et al. Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. East Mediterr Health J. 2019;25(1):47–57. 10.26719/emhj.18.014 [PubMed] [CrossRef]
Singh D, Agusti A, Anzueto A, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. European Respiratory Journal. 2019;53(5):05. 10.1183/13993003.00164-2019 [PubMed] [CrossRef]
Wheaton AG, Liu Y, Croft JB, et al. Chronic Obstructive Pulmonary Disease and Smoking Status - United States, 2017. MMWR Morb Mortal Wkly Rep. 2019;68(24):533–8. 10.15585/mmwr.mm6824a1 [PMC free article] [PubMed] [CrossRef]
Blanc PD, Annesi-Maesano I, Balmes JR, et al. The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement. American journal of respiratory and critical care medicine. 2019;199(11):1312–34. 10.1164/rccm.201904-0717ST [PMC free article] [PubMed] [CrossRef]
Balmes J, Becklake M, Blanc P, et al. American Thoracic Society Statement: Occupational contribution to the burden of airway disease. American journal of respiratory and critical care medicine. 2003;167(5):787–97. 10.1164/rccm.167.5.787 [PubMed] [CrossRef]
Diaz-Guzman E, Mannino DM. Epidemiology and prevalence of chronic obstructive pulmonary disease. Clin Chest Med. 2014;35(1):7–16. 10.1016/j.ccm.2013.10.002 [PubMed] [CrossRef]
National Clinical Guideline Centre. National Institute for Health and Clinical Excellence: Guidance. Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care. London: Royal College of Physicians (UK) National Clinical Guideline Centre - Acute and Chronic Conditions.; 2010.
